BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neganova ME, Klochkov SG, Aleksandrova YR, Aliev G. Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress. Semin Cancer Biol 2020:S1044-579X(20)30176-0. [PMID: 32814115 DOI: 10.1016/j.semcancer.2020.07.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Ren X, Tian S, Meng Q, Kim H. Histone Demethylase AMX-1 Regulates Fertility in a p53/CEP-1 Dependent Manner. Front Genet 2022;13:929716. [DOI: 10.3389/fgene.2022.929716] [Reference Citation Analysis]
2 Yang L, Zou T, Chen Y, Zhao Y, Wu X, Li M, Du F, Chen Y, Xiao Z, Shen J. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma. Hepatol Int 2022. [PMID: 35648301 DOI: 10.1007/s12072-022-10351-6] [Reference Citation Analysis]
3 Ahmad A. Special Issue: Epigenetic regulation of cancer progression: Promises and progress. Semin Cancer Biol 2021:S1044-579X(21)00298-4. [PMID: 34921992 DOI: 10.1016/j.semcancer.2021.12.005] [Reference Citation Analysis]
4 Neganova M, Liu J, Aleksandrova Y, Klochkov S, Fan R. Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment. Cancers (Basel) 2021;13:6062. [PMID: 34885171 DOI: 10.3390/cancers13236062] [Reference Citation Analysis]
5 Ibrahim TS, Malebari AM, Mohamed MFA. Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors. Pharmaceuticals (Basel) 2021;14:1177. [PMID: 34832959 DOI: 10.3390/ph14111177] [Reference Citation Analysis]
6 Neganova M, Aleksandrova Y, Suslov E, Mozhaitsev E, Munkuev A, Tsypyshev D, Chicheva M, Rogachev A, Sukocheva O, Volcho K, Klochkov S. Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer's Disease: Synthesis, Docking and Biological Evaluation. Pharmaceutics 2021;13:1893. [PMID: 34834312 DOI: 10.3390/pharmaceutics13111893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Porcuna J, Mínguez-Martínez J, Ricote M. The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders. Int J Mol Sci 2021;22:10573. [PMID: 34638914 DOI: 10.3390/ijms221910573] [Reference Citation Analysis]
8 Zhong S, Jeong JH, Huang C, Chen X, Dickinson SI, Dhillon J, Yang L, Luo JL. Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer. J Exp Clin Cancer Res 2021;40:307. [PMID: 34587977 DOI: 10.1186/s13046-021-02109-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xue T, Qiu X, Liu H, Gan C, Tan Z, Xie Y, Wang Y, Ye T. Epigenetic regulation in fibrosis progress. Pharmacol Res 2021;173:105910. [PMID: 34562602 DOI: 10.1016/j.phrs.2021.105910] [Reference Citation Analysis]
10 Bon C, Si Y, Pernak M, Barbachowska M, Levi-Acobas E, Cadet Daniel V, Jallet C, Ruzic D, Djokovic N, Djikić T, Nikolic K, Halby L, Arimondo PB. Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein. Molecules 2021;26:5300. [PMID: 34500733 DOI: 10.3390/molecules26175300] [Reference Citation Analysis]
11 Xiao Y, Zhou H, Jiang L, Liu R, Chen Q. Epigenetic regulation of ion channels in the sense of taste. Pharmacol Res 2021;172:105760. [PMID: 34450315 DOI: 10.1016/j.phrs.2021.105760] [Reference Citation Analysis]
12 Ning L, Rui X, Bo W, Qing G. The critical roles of histone deacetylase 3 in the pathogenesis of solid organ injury. Cell Death Dis 2021;12:734. [PMID: 34301918 DOI: 10.1038/s41419-021-04019-6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Chen S, Ben S, Xin J, Li S, Zheng R, Wang H, Fan L, Du M, Zhang Z, Wang M. The biogenesis and biological function of PIWI-interacting RNA in cancer. J Hematol Oncol 2021;14:93. [PMID: 34118972 DOI: 10.1186/s13045-021-01104-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Wang Y, Xie Q, Tan H, Liao M, Zhu S, Zheng LL, Huang H, Liu B. Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies. Pharmacol Res 2021;:105702. [PMID: 34102228 DOI: 10.1016/j.phrs.2021.105702] [Reference Citation Analysis]
15 Feng Z, Chen A, Shi J, Zhou D, Shi W, Qiu Q, Liu X, Huang W, Li J, Qian H, Zhang W. Design, synthesis, and biological activity evaluation of a series of novel sulfonamide derivatives as BRD4 inhibitors against acute myeloid leukemia. Bioorg Chem 2021;111:104849. [PMID: 33798846 DOI: 10.1016/j.bioorg.2021.104849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Mondal P, Natesh J, Penta D, Meeran SM. Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update. Semin Cancer Biol 2020:S1044-579X(20)30266-2. [PMID: 33309850 DOI: 10.1016/j.semcancer.2020.12.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
17 Audano M, Pedretti S, Ligorio S, Crestani M, Caruso D, De Fabiani E, Mitro N. "The Loss of Golden Touch": Mitochondria-Organelle Interactions, Metabolism, and Cancer. Cells 2020;9:E2519. [PMID: 33233365 DOI: 10.3390/cells9112519] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Khan P, Siddiqui JA, Maurya SK, Lakshmanan I, Jain M, Ganti AK, Salgia R, Batra SK, Nasser MW. Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease. Semin Cancer Biol 2020:S1044-579X(20)30240-6. [PMID: 33220460 DOI: 10.1016/j.semcancer.2020.11.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]